Home / Inspections / 1087821

FDA Inspection 1087821 — Bloodworks

Bloodworks — FEI 3071347

The FDA completed an inspection of Bloodworks on April 18, 2019 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 18, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seattle, WA (United States)

Facility

Other inspections at this facility

  • 1238690 (VAI Fri May 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1146276 (VAI Fri Jul 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1056331 (NAI Thu Jun 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1052060 (NAI Fri May 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027845 (NAI Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources